3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester [3-pyridinkarboxylová kyselina, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)fenyl)-, methyleste]
- Terms
-
Bay K 8644
-
Bay R5417
Bay-K-8644
Bay-K-8644, (-)-Isomer
Bay-K-8644, (+-)-Isomer
Bay-K-8644, (+)-Isomer
Bay-K8644
Bay-R-5417
BK-8644
A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.
- Annotation
- a calcium channel agonist
- DUI
- D001498 MeSH Browser
- CUI
- M0002232
- CAS
- 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester
- Previous indexing
- Nifedipine/analogs & derivatives (1975-1986); Pyridines (1966-1974)
- History note
- 87
- Public note
- 87
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives 1
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine